Medtronic Stock Hits New 52-Week High (MDT)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

NEW YORK ( TheStreet) -- Medtronic (NYSE: MDT) hit a new 52-week high Friday as it is currently trading at $40.80, above its previous 52-week high of $40.78 with 4.4 million shares traded as of 3:50 p.m. ET. Average volume has been 4.7 million shares over the past 30 days.

Medtronic has a market cap of $41.41 billion and is part of the health care sector and health services industry. Shares are up 5% year to date as of the close of trading on Thursday.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company has a P/E ratio of 12.5, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Medtronic Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning